Several GWAS studies have confirmed the presence of a homozygous deletion affecting an intron of FMN2 gene in some cases of ALS but not in controls (Table 1) [80, 110, 138]. This evidence concerns the gene FMN2 and amyotrophic lateral sclerosis.